1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Computational Biology Market Analysis By Application, By Service, By End User And Segment Forecasts To 2020

The global market for computational biology is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%. Steady increase in the usage & application of computational biology for bioinformatics R&D programs designed for sequencing genomes to better understand biological systems and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug discovery studies are expected to drive computational biology demand over the next six years.

Computational genomics for cellular and biological simulation applications dominated the market in 2013, accounting for over 47% of global revenue. Key factors driving demand for these applications include the growth of drug designing, disease modeling and personalized medicine applications and the growing usage of computational biology for functional and structural genomics, epigenomics and metagenomics for the analysis of protein transcription, protein-protein interactions, gene sequencing and expression and 3-dimensional protein structure analysis.

Further Key findings from the study suggest:

North America was the largest regional market, accounting for 58.0% of the global revenue in 2013. Its large share is majorly attributed to the growing research investments and initiatives for development of drug discovery, disease modeling technologies and innovations in biological computation methods. It is expected that Asia Pacific will witness the fastest growth in the market, at an estimated CAGR of 28.0% owing to the increasing expenditure in clinical studies for pharmacokinetics and pharmacogenomics.

The application of computational biology in proteomics for cellular simulation is expected to grow at the fastest CAGR of over 22% owing to the shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of development of personalized medicine.

Drug discovery and disease modelling applications dominated the market, accounting for 58.0% of global revenue in 2013. This large share is attributed by the extensive drug development pipelines present for a number of global branded and generic drug manufacturing firms such as Sanofi, Novo Nordisk and Eli Lilly.

Computational Biology databases dominated the tools segment and accounted for 44.5% of the market revenue in 2013, owing to extensive genomic database usage for warehousing and data mining of biological and sequential data generated from genomic and proteomic studies. Consequentially, the software and services for the analysis of biological data is expected to witness the fastest CAGR of over 21.0%.

Key players of this market include Schrodinger, Accelrys, Certara, Entelos, Simulation Plus and others.

For the purpose of this study, Grand View Research has segmented the computational biology market on the basis of applications, tools, services, end users and region:

- Computational Biology Application Outlook
- Cellular & Biological Simulation
- Computational Genomics
- Computational Proteomics
- Pharmacogenomics
- Others (Transcriptomics/Metabolomics)
- Drug Discovery and Disease Modelling
- Target Identification
- Target Validation
- Lead Discovery
- Lead Optimization
- Preclinical Drug Development
- Pharmacokinetics
- Pharmacodynamics
- Clinical trials
- Phase I
- Phase II
- Phase III
- Human Body Simulation Software
- Computational Biology Tools Outlook
- Databases
- Infrastructure (Hardware)
- Analysis Software & Services
- Computational Biology Services Outlook
- In-house
- Contract
- Computational Biology End User Outlook
- Academics
- Industry
- Commercial
- Computational Biology Regional Outlook
- North America
- Europe
- Asia Pacific
- RoW

Table Of Contents

Computational Biology Market Analysis By Application, By Service, By End User And Segment Forecasts To 2020
Table of Contents

Chapter 1. Executive Summary

1.1. Computational Biology - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Computational Biology Industry Outlook

2.1. Market Segmentation

2.2. Market Size and Growth Prospects

2.3. Computational Biology Market Dynamics

2.4. Key Opportunities Prioritized

2.5. Industry Analysis - Porter's

2.6. Computational Biology -Company Market Share Analysis, 2013

2.7. Computational Biology market PESTEL Analysis, 2013

Chapter 3. Computational Biology Application Outlook

3.1. Cellular and Biological Simulation

3.1.1. Global Computational Genomics demand, (USD Million), 2012 - 2020

3.1.2. Global Computational Proteomics demand, (USD Million), 2012 - 2020

3.1.3. Global Pharmacogenomics demand, (USD Million), 2012 - 2020

3.1.4. Global Transcriptomics/Metabolomics demand, (USD Million), 2012 - 2020

3.2. Drug Discovery andDisease Modelling

3.2.1. Global Target Identification market demand, (USD Million), 2012 - 2020

3.2.2. Global Target Validation market demand, (USD Million), 2012 - 2020

3.2.3. Global Lead Discovery market demand, (USD Million), 2012 - 2020

3.2.4. Global Lead Optimization market demand, (USD Million), 2012 - 2020

3.3. Preclinical Drug Development

3.3.1. Global Pharmacokinetics market demand, (USD Million), 2012 - 2020

3.3.2. Global Pharmacodynamics market demand, (USD Million), 2012 - 2020

3.4. Clinical trials

3.4.1. Global Phase I demand, (USD Million), 2012 - 2020

3.4.2. Global Phase II demand, (USD Million), 2012 - 2020

3.4.3. Global Phase III demand, (USD Million), 2012 - 2020

3.5. Human Body Simulation Software

3.5.1. Global Human body simulation Software demand, (USD Million), 2012 - 2020

Chapter 4. Computational Biology Tools Outlook

4.1. Global Databases demand, (USD Million), 2012 - 2020

4.2. Global Infrastructure(Hardware) demand, (USD Million), 2012 - 2020

4.3. Global Analysis Software and Services demand, (USD Million), 2012 - 2020

Chapter 5. Computational Biology Services Outlook

5.1. Global In-house Services demand, (USD Million), 2012 - 2020

5.2. Global Contract Services demand, (USD Million), 2012 - 2020

Chapter 6. Computational Biology End User Outlook

6.1. Global demand for Computational Biology in Academics, (USD Million), 2012 - 2020

6.2. Global demand for Computational Biology in Industrial Application, (USD Million), 2012 - 2020

Chapter 7. Computational Biology Regional Outlook

7.1. North America

7.1.1. Computational Biology market revenue by application, (USD Million), 2012 - 2020

7.1.2. Computational Biology market revenue by services, (USD Million), 2012 - 2020

7.1.3. Computational Biology market revenue by tools, (USD Million), 2012 - 2020

7.1.4. Computational Biology market revenue by end user, (USD Million), 2012 - 2020

7.2. Europe

7.2.1. Computational Biology market revenue by application, (USD Million), 2012 - 2020

7.2.2. Computational Biology market revenue by services, (USD Million), 2012 - 2020

7.2.3. Computational Biology market revenue by tools, (USD Million), 2012 - 2020

7.2.4. Computational Biology market revenue by end user, (USD Million), 2012 - 2020

7.3. Asia Pacific

7.3.1. Computational Biology market revenue by application, (USD Million), 2012 - 2020

7.3.2. Computational Biology market revenue by services, (USD Million), 2012 - 2020

7.3.3. Computational Biology market revenue by tools, (USD Million), 2012 - 2020

7.3.4. Computational Biology market revenue by end user, (USD Million), 2012 - 2020

7.4. RoW

7.4.1. Computational Biology market revenue by application, (USD Million), 2012 - 2020

7.4.2. Computational Biology market revenue by services, (USD Million), 2012 - 2020

7.4.3. Computational Biology market revenue by tools, (USD Million), 2012 - 2020

7.4.4. Computational Biology market revenue by end user, (USD Million), 2012 - 2020

Chapter 8. Computational Biology Competitive Landscape

7.1 Accelrys

7.1.1 Company Overview

7.1.2 Financial Performance

7.1.3 Product Benchmarking

7.1.4 Strategic Initiatives

7.2 Certara

7.2.1 Company Overview

7.2.2 Financial Performance

7.2.3 Product Benchmarking

7.2.4 Strategic Initiatives

7.3 Chemical Computing Group Inc.

7.3.1 Company Overview

7.3.2 Financial Performance

7.3.3 Product Benchmarking

7.3.4 Strategic Initiatives

7.4 Compugen Ltd

7.4.1 Company Overview

7.4.2 Financial Performance

7.4.3 Product Benchmarking

7.4.4 Strategic Initiatives

7.5 Entelos

7.5.1 Company Overview

7.5.2 Financial Performance

7.5.3 Product Benchmarking

7.5.4 Strategic Initiatives

7.6 Genedata AG

7.6.1 Company Overview

7.6.2 Financial Performance

7.6.3 Product Benchmarking

7.6.4 Strategic Initiatives

7.7 Insilico Biotechnology AG

7.7.1 Company Overview

7.7.2 Financial Performance

7.7.3 Product Benchmarking

7.7.4 Strategic Initiatives

7.8 Leadscope Inc

7.8.1 Company Overview

7.8.2 Financial Performance

7.8.3 Product Benchmarking

7.8.4 Strategic Initiatives

7.9 Nimbus Discovery LLC

7.9.1 Company Overview

7.9.2 Financial Performance

7.9.3 Product Benchmarking

7.9.4 Strategic Initiatives

7.10 Rhenovia Pharma SAS

7.10.1 Company Overview

7.10.2 Financial Performance

7.10.3 Product Benchmarking

7.10.4 Strategic Initiatives

7.11 Schrodinger

7.11.1 Company Overview

7.11.2 Financial Performance

7.11.3 Product Benchmarking

7.11.4 Strategic Initiatives

7.12 Simulation Plus Inc

7.12.1 Company Overview

7.12.2 Financial Performance

7.12.3 Product Benchmarking

7.12.4 Strategic Initiatives

Chapter 9. Methodology and Scope

8.1 Research Methodology

8.2 Research Scope and Assumptions

8.3 List of Data Sources


List of Tables

1. Computational Biology - Industry Summary and Critical Success Factors (CSFs)
2. Global Computational Biology market,(USD Million), 2012 - 2020
3. Global Computational Biology Market by Application, (USD Million), 2012 - 2020
4. Global Cellular and Biological Simulation Market, (USD Million), 2012 - 2020
5. Global Drug Discovery and Disease Modeling Market, (USD Million), 2012 - 2020
6. Global Preclinical Drug Development Market, (USD Million), 2012 - 2020
7. Global Clinical Trials Market, (USD Million), 2012 - 2020
8. Global Human Body Simulation Software Market, (USD Million), 2012 - 2020
9. Global Computational Biology Tools Market (USD Million), 2012 - 2020
10. Global Databases Market, (USD Million), 2012 - 2020
11. Global Hardware Infrastructure Market, (USD Million), 2012 - 2020
12. Global Analysis Software and Services Market, (USD Million), 2012 - 2020
13. Global Computational Biology Services Market , (USD Million), 2012 - 2020
14. Global In-house Services Market, (USD Million), 2012 - 2020
15. Global On-contract Services Market, (USD Million), 2012 - 2020
16. Global Computational Biology Market by End Users, (USD Million), 2012 - 2020
17. Global Market for Computational Biology in Academics, (USD Million), 2012 - 2020
18. Global Market for Computational Biology Industrial Use, (USD Million), 2012 - 2020
19. Global Market for Computational Biology in Commercial Products, (USD Million), 2012 - 2020
20. Global Computational Biology by Region, (USD Million), 2012 - 2020
21. North America Computational Biology Market by Application, (USD Million), 2012 - 2020
22. North America Computational Biology Tools Market, (USD Million), 2012 - 2020
23. North America Computational Biology Services Market, (USD Million), 2012 - 2020
24. North America Computational Biology Market by End User (USD Million), 2012 - 2020
25. Europe Computational Biology Market by Application, (USD Million), 2012 - 2020
26. Europe Computational Biology Tools Market, (USD Million), 2012 - 2020
27. Europe Computational Biology Services Market, (USD Million), 2012 - 2020
28. Europe Computational Biology Market by End User (USD Million), 2012 - 2020
29. Asia Pacific Computational Biology Market by Application, (USD Million), 2012 - 2020
30. Asia Pacific Computational Biology Tools Market, (USD Million), 2012 - 2020
31. Asia Pacific Computational Biology Services Market, (USD Million), 2012 - 2020
32. Asia Pacific Computational Biology Market by End User (USD Million), 2012 - 2020
33. RoW Computational Biology Market by Application, (USD Million), 2012 - 2020
34. Row Computational Biology Tools Market, (USD Million), 2012 - 2020
35. Row Computational Biology Services Market, (USD Million), 2012 - 2020
36. RoW Computational Biology Market by End User (USD Million), 2012 - 2020


List of Figures

1. Computational Biology Market Segmentation
2. Global Computational Biology Market Revenue, 2012 - 2020
3. Computational Biology Value Chain Analysis
4. Computational Biology Market Dynamics
5. Computational Biology - Company market Share Analysis, 2013
6. Key Opportunities Prioritized
7. Industry Analysis - Porter's
8. Computational Biology PESTEL Analysis, 2013
9. Computational Biology Market by Application, 2013and 2020
10. Global Computational Biology Market by Application, (USD Million), 2012 - 2020
11. Global Cellular and Biological Simulation Market, (USD Million), 2012 - 2020
12. Global Computational Genomics demand, (USD Million), 2012 - 2020
13. Global Computational Proteomics demand, (USD Million), 2012 - 2020
14. Global Pharmacogenomics demand, (USD Million), 2012 - 2020
15. Global Transcriptomics/Metabolomics demand, (USD Million), 2012 - 2020
16. Global Drug Discovery and Disease Modeling Market, (USD Million), 2012 - 2020
17. Global Target Identification demand, (USD Million), 2012 - 2020
18. Global Target Validation demand, (USD Million), 2012 - 2020
19. Global Lead Discovery demand, (USD Million), 2012 - 2020
20. Global Lead Optimization demand, (USD Million), 2012 - 2020
21. Global Preclinical Drug Development Market, (USD Million), 2012 - 2020
22. Global Pharmacokinetics demand, (USD Million), 2012 - 2020
23. Global Pharmacodynamics demand, (USD Million), 2012 - 2020
24. Global Clinical Trials Market, (USD Million), 2012 - 2020
25. Global Phase I Clinical Trials demand, (USD Million), 2012 - 2020
26. Global Phase II Clinical Trials demand, (USD Million), 2012 - 2020
27. Global Phase III Clinical Trials demand, (USD Million), 2012 - 2020
28. Global Human Body Simulation Software Market, (USD Million), 2012 - 2020
29. Computational Biology Tools Market (USD Million), 2013 and2020
30. Global Databases Market, (USD Million), 2012 - 2020
31. Global Hardware Infrastructure Market, (USD Million), 2012 - 2020
32. Global Analysis Software and Services Market, (USD Million), 2012 - 2020
33. Computational Biology Services Market , (USD Million), 2013 and2020
34. Global In-house Services Market, (USD Million), 2012 - 2020
35. Global On-contract Services Market, (USD Million), 2012 - 2020
36. Computational Biology Market by End Users, (USD Million), 2013and 2020
37. Global Market for Computational Biology in Academics, (USD Million), 2012 - 2020
38. Global Market for Computational Biology Industrial Use, (USD Million), 2012 - 2020
39. Global Market for Commercial Use of Computational Biology, (USD Million), 2012 - 2020
40. Computational Biology Market by Region, 2013and 2020
41. North America Computational Biology Market, (USD Million), 2012 - 2020
42. Europe Computational Biology Market, (USD Million), 2012 - 2020
43. Asia Pacific Computational Biology Market, (USD Million), 2012 - 2020
44. RoW Computational Biology Market, (USD Million), 2012 - 2020

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
The Chinese Market for DNA Sequencing

The Chinese Market for DNA Sequencing

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about recent advances and trends in the Chinese sequencing industry and market. - Analyze the Chinese sequencing market by workflow, including sample preparation products, ...

Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Glycobiology: Global Markets for Diagnostics and Therapeutics

Glycobiology: Global Markets for Diagnostics and Therapeutics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Evaluate new commercial opportunities in the glycobiology diagnostics, therapeutics and research tools market. - Analyze major market participants, including current and future ...


Download Unlimited Documents from Trusted Public Sources

Genetic Industry in the UK

  • November 2016
    26 pages
  • Genetic  

  • United Kingdom  

    Europe  

View report >

Genetic Industry in the UK

  • November 2016
    26 pages
  • Genetic  

  • United Kingdom  

    Europe  

View report >

Genome Sequencing Industry in Australia

  • November 2016
    126 pages
  • Genome Sequenci...  

  • Australia  

    United States  

View report >

Dna Industry In The Us

3 months ago

Dna Industry In The Us

5 months ago

Related Market Segments :

Computational Biology

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.